Lion Biotechnologies Obtains Exclusive License From NIH for Next-Generation TIL Technology Read more about Lion Biotechnologies Obtains Exclusive License From NIH for Next-Generation TIL Technology
Lion Biotechnologies Announces Its Listing on the Nasdaq Global Market Read more about Lion Biotechnologies Announces Its Listing on the Nasdaq Global Market
Lion Biotechnologies Appoints Ryan Maynard Director and Chair of Audit Committee Read more about Lion Biotechnologies Appoints Ryan Maynard Director and Chair of Audit Committee
Lion Biotechnologies Announces Public Offering of Common Stock Read more about Lion Biotechnologies Announces Public Offering of Common Stock
Lion Biotechnologies Prices Public Offering of Common Stock Read more about Lion Biotechnologies Prices Public Offering of Common Stock
Lion Biotechnologies to Present at Cowen and Company's 35th Annual Healthcare Conference Read more about Lion Biotechnologies to Present at Cowen and Company's 35th Annual Healthcare Conference
Lion Biotechnologies Announces Closing of Underwritten Public Offering of Common Stock and Full Exercise of the Underwriters' Option to Purchase Additional Shares Read more about Lion Biotechnologies Announces Closing of Underwritten Public Offering of Common Stock and Full Exercise of the Underwriters' Option to Purchase Additional Shares
Lion Biotechnologies Announces Positive Data From a TIL-Ipilimumab Combination Study in Melanoma Read more about Lion Biotechnologies Announces Positive Data From a TIL-Ipilimumab Combination Study in Melanoma
Lion Biotechnologies Announces Publication of Data From Clinical Study of Metastatic Cervical Cancer Patients Treated With HPV-TIL Read more about Lion Biotechnologies Announces Publication of Data From Clinical Study of Metastatic Cervical Cancer Patients Treated With HPV-TIL
Lion Biotechnologies Announces Pricing of Secondary Offering of Shares by Selling Stockholders Read more about Lion Biotechnologies Announces Pricing of Secondary Offering of Shares by Selling Stockholders